Log in

NASDAQ:PDLIPDL BioPharma SEC Filings & 10K Form

$3.44
+0.11 (+3.30 %)
(As of 08/4/2020 04:00 PM ET)
Add
Compare
Today's Range
$3.32
Now: $3.44
$3.46
50-Day Range
$2.71
MA: $2.98
$3.33
52-Week Range
$2.06
Now: $3.44
$3.86
Volume1.34 million shs
Average Volume1.22 million shs
Market Capitalization$391.97 million
P/E RatioN/A
Dividend YieldN/A
Beta0.87

SEC Filings

PDL BioPharma (NASDAQ:PDLI) SEC Filings

DateFilerForm TypeView
07/30/2020
7:44 AM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/28/2020
3:17 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2020
8:43 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2020
12:23 PM
PDL BioPharma (Filer)
Form DEF 14A
06/05/2020
3:22 PM
PDL BioPharma (Filer)
Form PRER14A
05/26/2020
3:34 PM
Evofem Biosciences, Inc. (Subject)
PDL BioPharma (Filed by)
Form SC 13D/A
05/21/2020
3:16 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/18/2020
3:08 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2020
8:32 PM
PDL BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/04/2020
6:47 AM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/21/2020
8:53 PM
Bazaar Alan Lee (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2020
8:52 PM
Bazaar Alan Lee (Reporting)
PDL BioPharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/07/2020
7:48 AM
PDL BioPharma (Issuer)
Stone Christopher Lewis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2020
7:47 AM
Imbrogno Edward (Reporting)
PDL BioPharma (Issuer)
Form 4/A
04/07/2020
7:47 AM
Monnet Dominique (Reporting)
PDL BioPharma (Issuer)
Form 4/A
04/07/2020
7:46 AM
Jene Jill M. (Reporting)
PDL BioPharma (Issuer)
Form 4/A
04/07/2020
7:46 AM
PDL BioPharma (Issuer)
Stone Christopher Lewis (Reporting)
Form 4/A
04/07/2020
7:46 AM
Imbrogno Edward (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2020
7:45 AM
Monnet Dominique (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2020
3:19 PM
PDL BioPharma (Filer)
Form DEFA14A
03/11/2020
3:16 PM
PDL BioPharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2020
7:33 AM
ENGINE CAPITAL, L.P. (Filed by)
PDL BioPharma (Subject)
Form SC 13D/A
02/28/2020
7:17 AM
PDL BioPharma (Filer)
Form DEFA14A
02/28/2020
7:15 AM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2020
11:04 AM
PDL BioPharma (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
01/15/2020
3:34 PM
PDL BioPharma (Filer)
Form DEFA14A
01/15/2020
11:32 AM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2020
5:37 PM
Imbrogno Edward (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2020
5:36 PM
PDL BioPharma (Issuer)
Stone Christopher Lewis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2020
5:36 PM
Monnet Dominique (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2020
5:36 PM
Jene Jill M. (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2020
2:26 PM
BRANDES INVESTMENT PARTNERS, LP (Filed by)
PDL BioPharma (Subject)
Form SC 13G
12/23/2019
6:59 AM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2019
7:33 AM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2019
7:34 AM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2019
7:33 AM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2019
7:04 AM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2019
12:21 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2019
3:14 PM
PDL BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2019
3:10 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2019
7:56 AM
ENGINE CAPITAL, L.P. (Filed by)
PDL BioPharma (Subject)
Form SC 13D
10/21/2019
6:05 AM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2019
3:08 PM
Evofem Biosciences, Inc. (Subject)
PDL BioPharma (Filed by)
Form SC 13D/A
09/17/2019
4:08 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2019
8:49 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2019
8:57 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2019
3:42 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2019
3:32 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2019
4:18 PM
Evofem Biosciences, Inc. (Subject)
PDL BioPharma (Filed by)
Form SC 13D/A
08/07/2019
3:22 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2019
4:02 PM
MCLAUGHLIN JOHN PETER (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
11:16 PM
PDL BioPharma (Filer)
Form EFFECT
06/25/2019
4:24 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2019
8:44 PM
PDL BioPharma (Issuer)
Yanai Shlomo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
8:41 PM
Hernday Natasha (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
8:40 PM
PDL BioPharma (Issuer)
Saks Samuel R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
8:39 PM
PDL BioPharma (Issuer)
SELICK HAROLD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
8:38 PM
GRYSKA DAVID W (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
8:37 PM
O'Farrell Elizabeth G. (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
8:36 PM
PDL BioPharma (Issuer)
Sandman Paul W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
8:34 PM
Hernday Natasha (Reporting)
PDL BioPharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/24/2019
8:32 PM
Imbrogno Edward (Reporting)
PDL BioPharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/24/2019
8:06 AM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2019
5:16 PM
Evofem Biosciences, Inc. (Issuer)
PDL BioPharma (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:02 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
3:07 PM
PDL BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2019
3:03 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2019
5:10 AM
PDL BioPharma (Filer)
Form DEFA14A
04/30/2019
4:14 PM
PDL BioPharma (Filer)
Form DEFA14A
04/30/2019
4:08 PM
PDL BioPharma (Filer)
Form DEF 14A
04/18/2019
2:33 PM
Evofem Biosciences, Inc. (Subject)
PDL BioPharma (Filed by)
Form SC 13D
04/18/2019
2:29 PM
Evofem Biosciences, Inc. (Issuer)
PDL BioPharma (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/16/2019
4:18 PM
Jene Jill M. (Reporting)
PDL BioPharma (Issuer)
Form 4/A
04/16/2019
4:17 PM
PDL BioPharma (Issuer)
Stone Christopher Lewis (Reporting)
Form 4/A
04/16/2019
4:16 PM
GARCIA PETER S (Reporting)
PDL BioPharma (Issuer)
Form 4/A
04/16/2019
4:15 PM
Monnet Dominique (Reporting)
PDL BioPharma (Issuer)
Form 4/A
04/16/2019
3:10 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2019
4:29 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2019
3:13 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2019
3:33 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2019
4:12 PM
Jene Jill M. (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
4:12 PM
GARCIA PETER S (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
4:11 PM
Monnet Dominique (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
4:10 PM
PDL BioPharma (Issuer)
Stone Christopher Lewis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2019
6:58 AM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2019
7:56 AM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2019
9:55 AM
PDL BioPharma (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
Form SC 13G/A
02/13/2019
9:09 AM
PDL BioPharma (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
02/08/2019
7:37 AM
DIMENSIONAL FUND ADVISORS LP (Filed by)
PDL BioPharma (Subject)
Form SC 13G/A
02/06/2019
2:05 PM
BlackRock Inc. (Filed by)
PDL BioPharma (Subject)
Form SC 13G/A
01/09/2019
9:26 AM
MCLAUGHLIN JOHN PETER (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
9:26 AM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2018
5:30 PM
Monnet Dominique (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2018
5:30 PM
GARCIA PETER S (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2018
5:29 PM
PDL BioPharma (Issuer)
Stone Christopher Lewis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2018
5:28 PM
MCLAUGHLIN JOHN PETER (Reporting)
PDL BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2018
7:21 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2018
8:18 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2018
3:03 PM
PDL BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2018
3:08 PM
PDL BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 8/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.